Annual FCF
-$19.08 M
-$3.04 M-18.94%
December 31, 2023
Summary
- As of February 8, 2025, VTVT annual free cash flow is -$19.08 million, with the most recent change of -$3.04 million (-18.94%) on December 31, 2023.
- During the last 3 years, VTVT annual FCF has fallen by -$1.08 million (-6.01%).
- VTVT annual FCF is now -18.94% below its all-time high of -$16.04 million, reached on December 31, 2022.
Performance
VTVT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$6.42 M
+$311.00 K+4.62%
September 30, 2024
Summary
- As of February 8, 2025, VTVT quarterly free cash flow is -$6.42 million, with the most recent change of +$311.00 thousand (+4.62%) on September 30, 2024.
- Over the past year, VTVT quarterly FCF has increased by +$311.00 thousand (+4.62%).
- VTVT quarterly FCF is now -1036.93% below its all-time high of $685.00 thousand, reached on June 30, 2022.
Performance
VTVT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$23.40 M
-$1.58 M-7.26%
September 30, 2024
Summary
- As of February 8, 2025, VTVT TTM free cash flow is -$23.40 million, with the most recent change of -$1.58 million (-7.26%) on September 30, 2024.
- Over the past year, VTVT TTM FCF has dropped by -$1.58 million (-7.26%).
- VTVT TTM FCF is now -126.11% below its all-time high of -$10.35 million, reached on June 30, 2022.
Performance
VTVT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
VTVT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.9% | +4.6% | -7.3% |
| 3 y3 years | -6.0% | -4.1% | +13.5% |
| 5 y5 years | +29.0% | -33.9% | -4.3% |
VTVT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.9% | +1.2% | -1036.9% | +27.3% | -126.1% | +13.5% |
| 5 y | 5-year | -18.9% | +17.4% | -1036.9% | +27.3% | -126.1% | +13.5% |
| alltime | all time | -18.9% | +60.5% | -1036.9% | +53.7% | -126.1% | +53.8% |
VTv Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.42 M(-4.6%) | -$23.40 M(+7.3%) |
| Jun 2024 | - | -$6.73 M(-8.3%) | -$21.81 M(+2.6%) |
| Mar 2024 | - | -$7.33 M(+151.7%) | -$21.25 M(+11.4%) |
| Dec 2023 | -$19.08 M(+18.9%) | -$2.91 M(-39.7%) | -$19.08 M(-17.2%) |
| Sep 2023 | - | -$4.83 M(-21.6%) | -$23.05 M(-14.8%) |
| Jun 2023 | - | -$6.17 M(+19.4%) | -$27.04 M(+33.9%) |
| Mar 2023 | - | -$5.17 M(-24.9%) | -$20.19 M(+25.8%) |
| Dec 2022 | -$16.04 M(-16.9%) | -$6.88 M(-22.1%) | -$16.04 M(+3.0%) |
| Sep 2022 | - | -$8.83 M(-1388.6%) | -$15.58 M(+50.6%) |
| Jun 2022 | - | $685.00 K(-167.1%) | -$10.35 M(-31.2%) |
| Mar 2022 | - | -$1.02 M(-84.1%) | -$15.03 M(-22.2%) |
| Dec 2021 | -$19.31 M(+7.3%) | -$6.42 M(+78.5%) | -$19.31 M(+27.8%) |
| Sep 2021 | - | -$3.59 M(-10.1%) | -$15.10 M(-10.9%) |
| Jun 2021 | - | -$4.00 M(-24.6%) | -$16.94 M(-4.5%) |
| Mar 2021 | - | -$5.30 M(+139.6%) | -$17.74 M(-1.5%) |
| Dec 2020 | -$18.00 M(-22.0%) | -$2.21 M(-59.3%) | -$18.00 M(-16.9%) |
| Sep 2020 | - | -$5.43 M(+13.4%) | -$21.66 M(-3.4%) |
| Jun 2020 | - | -$4.79 M(-13.8%) | -$22.43 M(-3.0%) |
| Mar 2020 | - | -$5.56 M(-5.4%) | -$23.13 M(+0.5%) |
| Dec 2019 | -$23.09 M | -$5.88 M(-5.1%) | -$23.02 M(+0.0%) |
| Sep 2019 | - | -$6.20 M(+12.7%) | -$23.01 M(-0.3%) |
| Jun 2019 | - | -$5.50 M(+0.9%) | -$23.08 M(-14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$5.45 M(-7.1%) | -$26.91 M(+0.2%) |
| Dec 2018 | -$26.86 M(-39.8%) | -$5.87 M(-6.3%) | -$26.86 M(-1.8%) |
| Sep 2018 | - | -$6.26 M(-32.9%) | -$27.34 M(-16.8%) |
| Jun 2018 | - | -$9.33 M(+72.9%) | -$32.85 M(-9.1%) |
| Mar 2018 | - | -$5.40 M(-15.0%) | -$36.16 M(-19.0%) |
| Dec 2017 | -$44.62 M(-7.6%) | -$6.35 M(-46.1%) | -$44.62 M(-10.2%) |
| Sep 2017 | - | -$11.78 M(-6.8%) | -$49.69 M(-1.9%) |
| Jun 2017 | - | -$12.64 M(-8.8%) | -$50.65 M(+2.0%) |
| Mar 2017 | - | -$13.86 M(+21.3%) | -$49.65 M(+2.8%) |
| Dec 2016 | -$48.30 M(+30.4%) | -$11.43 M(-10.2%) | -$48.30 M(+5.2%) |
| Sep 2016 | - | -$12.73 M(+9.3%) | -$45.90 M(+6.7%) |
| Jun 2016 | - | -$11.64 M(-6.9%) | -$43.01 M(+7.0%) |
| Mar 2016 | - | -$12.50 M(+38.4%) | -$40.18 M(+8.5%) |
| Dec 2015 | -$37.05 M(+20.2%) | -$9.03 M(-8.1%) | -$37.05 M(+5.9%) |
| Sep 2015 | - | -$9.83 M(+11.5%) | -$34.99 M(+13.9%) |
| Jun 2015 | - | -$8.82 M(-5.9%) | -$30.73 M(+5.4%) |
| Mar 2015 | - | -$9.37 M(+34.3%) | -$29.17 M(-5.3%) |
| Dec 2014 | -$30.81 M(-26.4%) | -$6.98 M(+25.3%) | -$30.81 M(+29.3%) |
| Sep 2014 | - | -$5.57 M(-23.3%) | -$23.84 M(+30.5%) |
| Jun 2014 | - | -$7.25 M(-34.1%) | -$18.27 M(+65.9%) |
| Mar 2014 | - | -$11.01 M | -$11.01 M |
| Dec 2013 | -$41.87 M | - | - |
FAQ
- What is vTv Therapeutics annual free cash flow?
- What is the all time high annual FCF for vTv Therapeutics?
- What is vTv Therapeutics annual FCF year-on-year change?
- What is vTv Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for vTv Therapeutics?
- What is vTv Therapeutics quarterly FCF year-on-year change?
- What is vTv Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for vTv Therapeutics?
- What is vTv Therapeutics TTM FCF year-on-year change?
What is vTv Therapeutics annual free cash flow?
The current annual FCF of VTVT is -$19.08 M
What is the all time high annual FCF for vTv Therapeutics?
vTv Therapeutics all-time high annual free cash flow is -$16.04 M
What is vTv Therapeutics annual FCF year-on-year change?
Over the past year, VTVT annual free cash flow has changed by -$3.04 M (-18.94%)
What is vTv Therapeutics quarterly free cash flow?
The current quarterly FCF of VTVT is -$6.42 M
What is the all time high quarterly FCF for vTv Therapeutics?
vTv Therapeutics all-time high quarterly free cash flow is $685.00 K
What is vTv Therapeutics quarterly FCF year-on-year change?
Over the past year, VTVT quarterly free cash flow has changed by +$311.00 K (+4.62%)
What is vTv Therapeutics TTM free cash flow?
The current TTM FCF of VTVT is -$23.40 M
What is the all time high TTM FCF for vTv Therapeutics?
vTv Therapeutics all-time high TTM free cash flow is -$10.35 M
What is vTv Therapeutics TTM FCF year-on-year change?
Over the past year, VTVT TTM free cash flow has changed by -$1.58 M (-7.26%)